S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Blue Owl Capital (OWL) Stock Price, News & Analysis

$18.26
-0.11 (-0.60%)
(As of 04/19/2024 08:51 PM ET)
Today's Range
$18.11
$18.57
50-Day Range
$17.31
$19.61
52-Week Range
$9.70
$19.87
Volume
2.49 million shs
Average Volume
4.41 million shs
Market Capitalization
$26.09 billion
P/E Ratio
182.62
Dividend Yield
3.07%
Price Target
$19.48

Blue Owl Capital MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.82 Rating Score
Upside/​Downside
6.7% Upside
$19.48 Price Target
Short Interest
Healthy
3.75% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.55mentions of Blue Owl Capital in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$71.15 M Sold Last Quarter
Proj. Earnings Growth
25.00%
From $0.84 to $1.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.04 out of 5 stars

Finance Sector

497th out of 849 stocks

Investment Advice Industry

30th out of 46 stocks

OWL stock logo

About Blue Owl Capital Stock (NYSE:OWL)

Blue Owl Capital Inc. operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants. It offers its solutions through permanent capital vehicles, as well as long-dated private funds. Blue Owl Capital Inc. is headquartered in New York, New York.

OWL Stock Price History

OWL Stock News Headlines

Global crypto currency reset (41 major banks signed up)
Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...
8 Analysts Have This To Say About Blue Owl Cap
Global crypto currency reset (41 major banks signed up)
Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...
Blue Owl Makes a Push Into Real Estate Finance
BLUE OWL CAPITAL ANNOUNCES SENIOR NOTES OFFERING
See More Headlines
Receive OWL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Blue Owl Capital and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/09/2024
Ex-Dividend for 3/5 Dividend
2/22/2024
Dividend Payable
3/05/2024
Today
4/21/2024
Next Earnings (Confirmed)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Investment advice
Sub-Industry
N/A
Fax
N/A
Employees
685
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$19.48
High Stock Price Target
$24.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+6.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.82
Research Coverage
11 Analysts

Profitability

Net Income
$54.34 million
Pretax Margin
14.23%

Debt

Sales & Book Value

Annual Sales
$1.73 billion
Cash Flow
$0.88 per share
Book Value
$3.73 per share

Miscellaneous

Outstanding Shares
1,428,800,000
Free Float
951,726,000
Market Cap
$26.09 billion
Optionable
Optionable
Beta
1.27
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Douglas Irving Ostrover (Age 62)
    Co-Founder, Chairman & Co-CEO
    Comp: $1.13M
  • Mr. Marc S. Lipschultz (Age 55)
    Co-Founder, Co-CEO & Director
    Comp: $1.13M
  • Mr. Michael D. Rees (Age 49)
    Co-Founder, Co-President, Head of Blue Owl's Dyal Capital Division & Director
    Comp: $703.27k
  • Mr. Craig William Packer (Age 58)
    Co-Founder, Co-President, Senior MD & Director
    Comp: $670.14k
  • Mr. Marc Zahr (Age 43)
    Co-President & Director
    Comp: $500k
  • Mr. Alan J. Kirshenbaum CPA (Age 53)
    Chief Financial Officer
    Comp: $4.11M
  • Mr. Sean Ward J.D. (Age 44)
    Senior MD & Director
    Comp: $6.75M
  • Mr. Andrew Robert Polland (Age 49)
    Chief Operating Officer
  • Ms. Ann Dai
    MD & Head of Investor Relations
  • Ms. Neena A. Reddy (Age 46)
    MD, General Counsel & Secretary

Should I Buy Blue Owl Capital Stock? OWL Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Blue Owl Capital Inc.:

  • Blue Owl Capital Inc. has shown consistent growth in revenue, with a return on equity of 17.31% and a net margin of 3.14%, indicating strong financial performance.
  • The company recently declared a quarterly dividend, offering shareholders a dividend payout ratio of 560.06% and a yield of 2.96%, providing potential income for investors.
  • Analysts have upgraded Blue Owl Capital's stock rating, with price targets being raised and buy ratings being given, suggesting positive sentiment and potential future price appreciation.
  • Institutional investors, such as Price T Rowe Associates Inc. MD and Capital International Investors, have significantly increased their stakes in Blue Owl Capital, indicating confidence in the company's growth prospects.
  • Blue Owl Capital's stock price has been on an upward trend, with sell-side analysts predicting positive earnings per share (EPS) for the current fiscal year, making it an attractive investment opportunity.

Cons

Investors should be bearish about investing in Blue Owl Capital Inc. for these reasons:

  • Blue Owl Capital's dividend payout ratio of 560.06% may raise concerns about the sustainability of the dividend payments and the company's financial health in the long term.
  • While the company has shown growth, the stock's price volatility and market risks associated with asset management firms could lead to fluctuations in investment returns.
  • Major shareholders, like Path Solutions 2020 L.P Glide, have sold significant amounts of Blue Owl Capital's stock, potentially signaling insider concerns or lack of confidence in the company's future performance.
  • Despite positive analyst ratings, the stock may be subject to market sentiment shifts, regulatory changes, or economic downturns that could impact its valuation and investor returns.
  • Investors should carefully consider the competitive landscape and industry challenges faced by Blue Owl Capital, as well as the broader economic conditions that could affect the company's growth trajectory.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, April 13, 2024. Please send any questions or comments about these Blue Owl Capital pros and cons to contact@marketbeat.com.

OWL Stock Analysis - Frequently Asked Questions

Should I buy or sell Blue Owl Capital stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Blue Owl Capital in the last year. There are currently 2 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" OWL shares.
View OWL analyst ratings
or view top-rated stocks.

What is Blue Owl Capital's stock price target for 2024?

11 equities research analysts have issued 1 year target prices for Blue Owl Capital's stock. Their OWL share price targets range from $15.00 to $24.00. On average, they predict the company's stock price to reach $19.48 in the next twelve months. This suggests a possible upside of 6.7% from the stock's current price.
View analysts price targets for OWL
or view top-rated stocks among Wall Street analysts.

How have OWL shares performed in 2024?

Blue Owl Capital's stock was trading at $14.90 at the beginning of the year. Since then, OWL stock has increased by 22.6% and is now trading at $18.26.
View the best growth stocks for 2024 here
.

Are investors shorting Blue Owl Capital?

Blue Owl Capital saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 17,390,000 shares, a drop of 19.6% from the February 29th total of 21,640,000 shares. Based on an average daily trading volume, of 4,430,000 shares, the short-interest ratio is currently 3.9 days. Currently, 3.8% of the shares of the company are sold short.
View Blue Owl Capital's Short Interest
.

When is Blue Owl Capital's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our OWL earnings forecast
.

How can I listen to Blue Owl Capital's earnings call?

Blue Owl Capital will be holding an earnings conference call on Thursday, May 2nd at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Blue Owl Capital's earnings last quarter?

Blue Owl Capital Inc. (NYSE:OWL) issued its earnings results on Friday, February, 9th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.17 by $0.01. The firm had revenue of $494.04 million for the quarter, compared to analyst estimates of $438.77 million. Blue Owl Capital had a net margin of 3.14% and a trailing twelve-month return on equity of 17.31%. During the same period in the prior year, the company earned $0.15 EPS.

How often does Blue Owl Capital pay dividends? What is the dividend yield for Blue Owl Capital?

Blue Owl Capital announced a quarterly dividend on Friday, February 9th. Shareholders of record on Friday, February 23rd will be given a dividend of $0.14 per share on Tuesday, March 5th. This represents a $0.56 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date of this dividend is Thursday, February 22nd.
Read our dividend analysis for OWL
.

Is Blue Owl Capital a good dividend stock?

Blue Owl Capital (NYSE:OWL) pays an annual dividend of $0.56 per share and currently has a dividend yield of 3.07%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 560.06%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, OWL will have a dividend payout ratio of 53.33% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for OWL.

Who are Blue Owl Capital's major shareholders?

Blue Owl Capital's stock is owned by a number of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.18%), Los Angeles Capital Management LLC (0.08%), TrueMark Investments LLC (0.01%), Oliver Luxxe Assets LLC (0.00%), Toth Financial Advisory Corp (0.00%) and Capital Insight Partners LLC (0.00%). Insiders that own company stock include Blue Pool Capital Ltd, Claudia A Holz and Path Solutions 2020 LP Glide.
View institutional ownership trends
.

How do I buy shares of Blue Owl Capital?

Shares of OWL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:OWL) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners